Background: The amalgamation of biological sciences with nano stuff has significantly expedited the progress of biological strategies, greatly promoting practical applications in biomedical fields.
INTRODUCTION
Nanotechnology is one of the most emerging fields of science in the last decade. With the emergence of modern technologies and a better understanding of nano-science, this advancement has proved to be a boon, increasing its application in medical, clinical, biomedical and pharmaceutical science, and more specifically in the field of disease diagnosis, imaging, drug delivery and therapeutics [1, 2] . However, to predict their behaviour in the biological system and to design them in a way that they get easily excreted after performing their function is extremely difficult [3] . Nanoparticles also trigger some irritation reactions and even stimulate many chemical releases which can alter the condition [3] . To predict the drug release pattern of a nanoparticle system is also difficult as when they enter the body, they get surrounded by phagocytic cells. Another problem with them is to extract them from the body after they have performed their function. Despite the fact that nanomedicine has been widely studied for overcoming challenges of tumour targeted delivery and adaptive resistance to therapy, it is due to the advantages that nanocarriers provide like multifunctionality that enables the accommodation of drugs, affinity ligands, as well as imaging moieties all within a single nanoparticle carrier which can be exploited as A targeted and traceable delivery system [4] . In some recent studies, development of novel drug delivery vehicles composed of lipids, polymers, carbon materials, nanocrystals or even hybrid combinations has been found to drastically improve pharmacological properties of conventional therapies and has also enabled the delivery of newer classes of potent anti-cancer drugs in gene therapy and immunotherapy [5, 6] . These tailored drug delivery systems offer better pharmacokinetic properties, therapeutic efficacy and are even successful in reducing the side effects. Among the nanoparticle systems, the most widely discussed ones are buckyballs, fullerenes, carbon tubes, liposomes, nano-shells, dendrimers etc. [7, 8] and among them, Quantum dots (QDs) have gained popularity in recent times. Apart from being a carrier for drug delivery, QDs can also act as a model platform as a diagnostic agent. QDs are complemented with features like small size, versatile surface chemistry and exceptional optical properties [4] .
INSIGHTS INTO QDS
Quantum dots are semiconductor crystals in the nanoscale range of 1-10 nm. They have the capacity to fluorescence or glow on being excited by a light source. They are usually made up of materials such as silicon, cadmium selenide, indium arsenide or cadmium sulphide. They are able to glow a particular colour after being illuminated by a light source. The glow is dependent on the size of the nanoparticle. The quantum dots hold unique photophysical properties such as large absorption coefficients, size-adjustable light emission, superior signal brightness, resistance against photobleaching, emission of multiple fluoresce colours which made it unique from other nano particles [4, 9] .
WHAT MAKES QD TO FLUORES-CENCE?
When a quantum dot is illuminated, some of the electrons from its outer shell receive enough energy to break free allowing them to move around the atom thus creating a conduction band. Electrons in this conduction band are free to move through a material and are able to conduct electricity. When these excited electrons fall back to the valence band, they are able to emit a specific colour of light ( Fig. 1) . The colour of the light depends on the difference in energy between the excited or conduction band and the valence band. It has been studied that the higher the energy difference between the conduction band and the valence band, the emission light turns to the deeper blue colour, however, if the difference is lower, it shifts the glow towards the red band of the VIBGYOR colour spectrum.
METHOD OF FABRICATION OF QDS
Method of preparation of QDs has evolved over a period of time. Previously synthesized quantum dots had poor size distribution and low fluorescence efficiency. During the mid-1990s, the chemical synthesis of semiconductor quantum dots was proposed by Murray et al. Different researchers discussed different methods to synthesize more efficient quantum dots. Some of the important methods of synthesis of QDS are discussed in the below table (Table 1 ) [9] .
Modifications in the Surface Properties of QDs
QDs are usually prepared using organic or aqueous solvents, which in the current form are unsuitable for biological purposes. Thus, surface modification is required to make the quantum dots suitable for biological applications [10] [11] [12] . The application of quantum dots as biological tools depends on their physiochemical and photophysical properties ( Fig. 2) . QDs which are prepared in an aqueous media provide water-soluble properties but with a drawback of monodispersity of the particles, crystallinity, fluorescence and stability. Organic solvents give QDs with hydrophobic surfaces. These surfaces are modified to make them feasible for biological application [13] [14] [15] . The two Table 1 . Processfor synthesis of quantum dots.
Type of Synthesis Method Pros Example References
High temperature synthesis Cadmium oxide (CdO), trioctylphosphine oxide (TOPO), and either hexylphosphonic acid (HPA) or tetradecylphosphonic acid (TDPA) as ligands at 250-300°C were used to generate a colourless solution. In which tellurium (Te), selenium (Se), and sulfur (S) stock solutions were added. Use of dimethyl cadmium (Cd(CH 3 ) 2 ) as precursor may be dangerous as it is extremely toxic and releases large amount of explosive gas.
High-quality monodisperse QDs.
Cd-HPA-CdTDPA complexes [16, 17] γ-Irradiation
ZnS preparation is less studied compared with CdSe, because ZnS posse's optical properties already in the UV region even before quantum confinement is attained.
Different size can be prepared by controlling γ-ray absorption dose, surfactant concentration, and Na 2 S 2 O 3 concentration. zinc sulfide (ZnS) QDs [18] [19] [20] Microwaveassisted synthesis Chloroauric acid HAuCl4 is reduced in methanol for 0.5-5 min in the presence of a water-soluble polymer surfactant such as polyvinylpyrrolidone (PVP) synthesises small spherical monodispersed QDs. PVP helps as a stabilizer in the process and the microwave heating, which is used in between 480 and 1100 W. The synthesis occurs rapidly with the diameter of the Au QDs formed within the quantum confinement region of <11 nm.
The absence of convection processes while heating giving a homogeneous vessel temperature for uniform nucleation and growth, as well as shorter crystallization time.
cadmium sulfide (CdS), cadmium selenide (CdSe) QDs [21] [22] [23] Langmuir-Blodgett films Langmuir-Blodgett films as matrices in which QDs can be first propagated and then grown in a controlled manner. This occurs because of the dual amphiphilic properties of these bilayer films.
QD with desired thickness can be developed.
ZnS, PbS, and a PbS-CdS combination of QDs [24, 25] Polyol methods Diethylene glycol and acetates of relevant metals Zn and Cd, was mixed with thiourea(10%). To synthesize the nanoparticle the acetate mixtures nanoparticles was then heated for 2 h at 180°C.
QDs formed are stable for several days; no agglomeration of particles.
CdS and ZnS QDs [26, 27] Sol-gel methods Solution containing Cd and Se are grown at low temperatures to form a wet gel due to the heat treatment. It gives quantum dots of 4-20 nm size.
Simple and cheap process.
Gold, Zinc, Copper, Cadmium, Selenium Quantum dots [28, 29] Core-shell QDs It consists of a core-shell with an overcoating of nanocrystallites such as CdSe with an inorganic material like ZnS having higher band gap.
Excellent photostability, electronic accessibility, high quantum yield.
CdSe-CdS core-shell nanocrystals [30, 31] 
Type of Conjugation Description Example References

Transferrin-conjugated QDs
Transferrin is covalently attached to the surface of the QDs. It luminescence 20 times brighter and 100 times more stable.
CdSe-ZnS dots with TF [32]
Immunoglobulin Gstreptavidinconjugated QDs IgG coupling is done on the dried film of neutralized amphiphilic polymers cross-linked to 1-ethyl-3 -(3dimethylaminopropyl) carbodiimide (EDC)-mediated coupling to lysine (or PEG-lysine).
QD-IgG; QDstreptavidin [33] Engineered virus conjugation Engineered viruses are organized over the three-dimensional arrangement of QDs.
ZnS QDs with M13 bacteriophage virus [34] TAT peptide and DNA-QDs conjugate HIV TAT-derived peptide has been found to be capable of delivering molecules like proteins, peptides and nucleic acid. CdSe-ZnS (655 nm) were incubated with a bissulfosuccinimidylsuberate (BS3) cross-linker and then incubated with a cardiac troponin (cTnC). The formed protein-QD samples were then incubated with either unlabeled C-TAT or C-TAT-HA2. The cTnC and the peptide were covalently attached on to the QDs to provide QD-cTnCS-S-TAT and QD-cTnC-S-S-TAT-HA2 complexes.
QD-cTnC-S-S-TAT-HA2 complexes; Plasmid DNA labled QD [35] [36] [37] common approaches in this regard are ligandexchange strategy and ligand capping or encapsulation. In ligand-exchange, the residual surface ligands are completely replaced with an amphiphilic molecule whereas in ligand capping, the amphiphilic molecules are used to cap the hydrophobic ligands [32, 33, 38, 39] .
Bio-Conjugation of QDs
The surface modified quantum dots need to be conjugated with a biomolecule like DNA, siRNA, antibodies, and oligonucleotides. The conjugated QDs possess in vivo imaging, specific binding and targeting capabilities [4] . Different types of bioconjugated quantum are enlisted in Table 2 .
APPLICATIONS OF QDS
QDs as Diagnostic Agents
QDs are widely used as cancer diagnostic agents [40] . QDs coated with polyacrylate cap and covalently linked to antibodies have been exploited to diagnose breast cancer. Antibody-linked QDs have also been used to diagnose Respiratory Syncytial Virus infection. Researchers have also reported in vivo imaging with QDs with a core of T2-MP EviTags in tumor-bearing mice [41] . QDs have also been reported for the diagnosis of brain tumor by antibodies labeled as QDs which help in visualizing epidermal growth factor receptor (EGFR) expression in human brain tumor cells. Streptavidin-coated quantum dots (QDs) were conjugated to anti-EGFR antibodies incubated with target cultured tumor cells and tissues. The bioconjugated QDs were found to bind selectively to brain tumor. QDs have also been exploited to detect pathogens and toxins. However, one study suggests that the sensitivity of QDS is lesser than ELISA based techniques for the detection of pathogens and toxins [42] . Muthusankar et al. (2018) disclosed the synthesis of sulfur-doped carbon quantum dots (S-CQDs) chemically incorporated with iron oxide nanoparticles (S-CQDs/Fe2O3) using hydrothermal synthesis strategy. A novel electrocatalyst was used for the detection of antipsychotic drug olanzapine (OLZ) in samples (urine etc) via S-CQDs/Fe2O3 nanocomposite modified glassy carbon electrode. Exceptionally, this electrode exhibits good electrocatalytic activity for OLZ oxidation and also shows a very low detection limit and sensitivity of about 0.006 μM and 0.88 μA μM-1 cm-2 respec-tively. Additionally, the proposed sensor has been applied for the detection of OLZ in urine samples [43] .
QDs as a Drug Carrier System
Hydrophobic drugs can be embedded in between the inorganic core and an amphiphilic coating layer of the polymer. The exploitation of QDs as a drug carrier is dependent on the size of the QDs. The optimum size of QDs is important for targeted delivery because small-sized QDs were found to be cleared by renal filtration and larger sized QDs are likely to be uptaken by the reticuloendothelial system. The optimum size of QDs to serve as a drug carrier is suggested to be 5-20 nm. Hydrophilic therapeutic agents (including small interfering RNA [siRNA]) and antisense oligodeoxynucleotide [ODN] and targeting biomolecules (such as antibodies, peptides and aptamers) are loaded on to QDs. These QDs act as magic bullets and provide targeted delivery of drugs as well as detectable signals for monitoring [44] .
Oliveira et al. reported the synthesis and characterization of smart drug delivery carriers platform and the efficacy of these smart carriers system was demonstrated through the successful extraction and recognition of proteins in a raw serum of osteoarthritis and prosthesis patients, without any previous protein depletion. The smart carriers system was prepared by luminescent CdTe quantum dots coated with modified mesoporous silica nanoparticles. These particles lead to pore size augmentation, permitting better encapsulation and controlled release, of different active principles studied such as, small molecules (rhodamine B), drugs (doxorubicin), and isolated proteins such as bovine serum albumin, lysozyme, carbonic anhydrase, ovalbumin, α-lactalbumin, hemoglobin, myoglobin and cytochrome C. The luminescent QDs permit the imaging of the nanoparticles during cell internalization, as well as the visualization of selective release of doxorubicin inside the cell (via pH stimuli) [45] .
The invention discloses the optimization of the liposomal formula of aptamer-conjugated liposomes containing Q-dots and siRNA molecules (Apt-QLs). Tumor-Targeted lipid nanocarriers are fabricated by coupling of aptamer molecules against the EGF receptor (EGFR) to the distal ter-mini of lipid nanoparticles, provided the carrier with tumor-specific recognition capability. The cationic lipid component, selected as O,O'dimyristyl-N-lysyl glutamate (DMKE), was able to bind with anionic small-interfering RNA (siR-NA). The hydrophobic quantum dots (Q-dots) were effectively integrated into hydrophobic lipid bilayers at an appropriate Q-dot to cationic lipid ratio. The anti-EGFR Apt-QLs are used as a carrier for tumor-directed gene delivery, EGFRdependent siRNA delivery, and fluorescence imaging/bio-imaging for the treatment of cancer [46] .
QDs for the Detection of Cell Death
A combination of QDs with an MRI agent like gadolinium helps detect cells undergoing apoptosis. The combination is capable of providing cellular level information using fluorescence imaging. This helps in detecting whether an antitumor therapy is killing cancer cells or not. The combination is able to provide 40 times stronger imaging signals as compared to gadolinium carrier alone [44, 47] .
QDs in Immunoassay
Baoquan et al. studied an immunoassay based fluorescent imaging analysis with laser confocal scanning. The ZnS-coated CdSe quantum dots (ZnS/CdSeQDs) were linked to a detection antibody. Immunoassay was carried out on a glass chip using a sandwich assay approach, where the antibody covalently bound to a glass chip could capture the antigen. Afterward, the detection antibody labelled with QDS could bind selectively to the captured antigen. The fluorescent signals of the sandwich conjugate were detected by a laser confocal scanner [48] .
QDs in Neuroscience
QDs can be used to visualize, measure and track molecular events using fluoresce microscopy. With the small size and optical resolution, they are able to reach and detect the anatomy of neuronal and glial interactions, synaptic cleft, astrocyte process and neurons. Antibody-functionalized quantum dots are used to track the lateral diffusion of glycine receptors in cultures of primary spinal cord neurons. They were able to track the trajectory of individual glycine receptors for tens minutes at spatial resolutions of 5-10 nm, demonstrating that the diffusion dynamics varied depending on whether the receptors were synaptic, presynaptic, or extrasynaptic [48] [49] [50] .
The brain function depends on the structure of negatively charged cell surface proteoglycans and sialoglycoconjugates in the brain. The invention compared three zwitterionic quantum dots (QDs) coatings differing only in their regions of positive or negative charge, as well as a positively charged (NH2) polyethylene glycol (PEG) coat, for their ability to deliver the cell-membrane-penetrating chaperone lipopeptide JB577 (WG(Palmitoyl) VKIKKP9G2H6) to individual cells in neonatal rat hippocampal slices. The results displayed the preferential uptake in neurons, and the lack of uptake in glia are strongly associated with having a region of greater negative charge on the QDS coating. Furthermore, the role of negatively charged chondroitin sulfate of the extracellular matrix (ECM) in restricting uptake was further suggested by digesting neonatal rat hippocampal slices with chondroitinase ABC and exhibiting enhanced uptake of QDs by oligodendrocytes. Treatment with QDs has not affected the uptake in astrocytes or microglia. Finally, the future prospects of using QDs as vehicles for trafficking proteins into cells continue to show promise, as by administering a histidinetagged green fluorescent protein (eGFP-His6) to hippocampal slices, the neuronal uptake of GFP can be observed [51] .
QDs in RNA Interference (iRNA)
RNAi is gaining popularity in regulating gene expressions and resisting viruses and mutations [52, 53] . QDs are now being exploited to carry an image on siRNA (Small interfering RNA) due to their phenomenal optical properties. However, their study is limited to animal level as their potential use in humans as a drug delivery vehicle is still unclear because of the fact that bioconjugated QDs have low clearance from the body in the form of either intact particle or ions [54, 55] . Zhu et al. (2014) synthesized cadmium (Cd) telluride (Te) quantum dots (CdTeQDs) by a hydrothermal method using three different ligands such as stabilizers, N-acetyl-L-cysteine (NAC), cysteamine hydrochloride (CA), or 2-(dimethyl-amino) ethanethiol hydrochloride (DMAE). The outcomes of the invention showed that CA-coated CdTeQDs had a higher zeta potential (positive) compared with the NAC-and DMAE-coated CdTeQDs. Moreover, CA-coated CdTeQDs had the greater ability to bind siRNA and perfrom a greater uptake by human gastric cancer cells (SGC-7901). The release rate of siRNA from the surface of CdTeQDs was induced by high concentrations of reduced glutathione (GSH). mRNA and protein levels of HIF-lα in SGC-7901 cells were significantly reduced after being treated with the complex of CA-coated CdTeQDs and HIF-lα siR-NA under strict anaerobic conditions. It was concluded that CA-coated CdTeQDs demonstrated good optical properties, good morphology, and low toxicity toward the normal cells [56] .
QDs in Pharmacokinetic Studies
QDSFRET (Förster resonance energy transfer) method is being exploited to study drug release kinetics. It works under the principle that when fluorescence emission spectrum of QDs and excitation spectrum of fluorescent receptors overlap and the spatial distance between the donor and acceptor is close enough; the QDs at the state of excitation act as a fluorescence donor to the acceptor which in turn results in fluorescence. This method has been used to study biological macromolecules, immunoassay, nano-drug release kinetics etc. [53] .
Effects of QDs on Toxicity Studies
It is a well-known fact that the toxic effects of QDs are being exploited for biomedical application especially in targeting tumor cells. However, there is always a possibility that QDs core degradation, free radical formation and QDs interaction with intracellular components may result in cytotoxicity. A number of factors have been proposed to influence cytotoxicity like the size of QDs, surface chemistry, coating bioactivity and processing parameters (toxicity studies). There are a very few reports related to pharmacological and toxicological animal studies. Studies which provide evidence on toxicity are enlisted in Table 3 . Various parameters are being studied to manage or eliminate the toxic effects of QDs. The parameters which are reported to influence the toxic effects of QDs are enlisted in Table 4 . QDs come with toxicity which Table 3 . Animal studies that establishes toxicological effects of QDS.
Quantum Dots Toxicity Model Used References
Uncoated CdTe QD Organ damage, Disturbances to the motor function Rat models [57] CdSe/ZnS -SSA Cytotoxic, Altered cell growth EL-4 lymphoma cells [58] CdSe/ZnS -MUA DNA damage WTK1 cells A [59] CdTe Cytotoxic Murine microglial cells, Rat pheochromocytoma cells.
[60] Table 4 . Parameters reported to influence toxic effects of QDs.
Parameter Inference References
Particle size 2.2 nm CdTe QD had greater toxicity as compared to 5.2 nm particles. Smaller particles were localized in and around the nucleus of the cell, whereas the larger particles (approximately 2.5 nm) were located within the cytoplasm.
[60]
Dose
Higher dose may possess more chances of toxicity. [61] Residence time Long residence time in tissues may have more chances of toxicity. [57] Metabolism Lesser excretion of QDs may possess higher chances of toxicity. [57] limits their application. However, with better scientific knowledge, new approaches are being developed to remove toxicity from QDs. In a novel approach, gelatin is being used for the production of CdTeQDs thereby reducing the toxic effects of cadmium. Proper coating can also be exploited to reduce the acute toxicity of QDs.
Another approach could be controlling the parameters which influence the toxicity of QDs during their production [62, 63] .
This invention aims to synthesise and characterise a pH-responsive drug release system based on cadmium telluride quantum dots capped by the fluorescent dye-labeled poly (N-(2-(2-amino-ethylamino)-ethyl methacrylamide) metal-chelating polymer. The fluorescent dye is a model for an active constituent which depicts the polymer that may be attached to bioactive agents such as an antibody or a functional drug. Moreover, it indicates the success of ligand exchange between anchor groups on the polymer surface and QDs. The prepared nanoparticles show low cytotoxicity in cell viability studies. The release rates of Dox (Doxorubicin) drug conjugates were studied at pH 5.4 and pH 7.4, wherein, the release rates of doxorubicin (DOX) anticancer drug conjugates were studied at pH 5.4 and pH 7.4. The release rates of DOX in pH 7.4 (pH of normal cells) was found to be <1%, while it was high at pH 5.4 (pH of cancer cells) [59] .
MARKET RESEARCH ON THE RECENT ADVANCEMENT
Quantum dots are still in the development stages. Various applications of quantum dots have been reported by industries, and are highlighted in this section ( Table 5 ). As their ability to couple biological recognition agents to QDs slowly develops, we can expect more commercial products incorporating QDs for treatment, diagnostic, and research purposes. The quantum dots market was estimated to be USD 1.96 billion in 2017 which is expected to achieve at USD 8.47 billion by 2023, at a CAGR of 26.97% during the forecast period [64, 65] . The quantum dots market for cancer imaging / personalized medicine would reach $750 million and quantum dot ID Tags $700 million dollars by 2021. The major players such as antibodies incorporated, attonuclei, cromozinc, di-agnano, helicos biosciences corporation, luminex corporation and nanoco group plc are still at the research stage for the development of quantum dots especially in biomedical or pharmaceutical applications [70].
FUTURE PROSPECTS
Despite the fact that numerous investigations have been attracted highlighting the potential long term toxicities of QDs in various cellular and animal models, the toxicity studies of QDs, however, remain arguable. These studies have still been prevailed during the recent years, mainly regarding the disposition of QDs in nonhuman primates. The in-vivo performance of QDs should be systematically studied before their further clinical applications. Although there is a long way to go for the use of QDs in human beings, we strongly believe that the advancements in the field of science and technology particularly nanotechnology will move biocompatible QDs forward to the real clinical applications in the near future. The quantum dots have the ability to couple with biological recognition agents, which unlock their application in vari-ous sectors so we can expect more commercial products incorporating QDs for treatment, diagnosis, and research purposes.
CONCLUSION
This review article outlines the latest advancements in attributes, preparation methods, applications, toxicity of QDs, and commercial products which substantiate that QDs possess great competence for medical research, diagnostics, and radical approaches of drug delivery, tumor ablation and tumor treatment. Notably, QDs as a new type of smart nao-systems for neuroscience and pharmacokinetic studies have been discussed. Surface amicabilities of QDs with a diverse biomolecule (e.g. DNA, siRNA, oligonucleotides, etc.) offer favorable circumstances for employing them in biomedical studies. Most importantly, the unification of QDs with novel nanocarriers (e.g. liposomes, polymeric micelles, and nanoparticles) may form a versatile approach for targeted drug delivery, clinical diagnosis and cancer treatment. Hence researchers are making great efforts to solve these problems associated with QDs, generally by coat- Qdot ® 655 ITK™ amino (PEG) quantum dots are the ideal starting material for preparing custom conjugates of ultrabright and photostable fluorescently labeled proteins or other biopolymers. It may be used for various labeling and tracking applications that require ultrabright and stable fluorescence.
[66]
Evident Technologies, Inc EviFluors ® EviFluors are ready-to-use high quality, activated quantum dots coupled to secondary antibodies and proteins. Goat anti-Mouse, Goat anti-Rabbit, Goat anti-Rat, Streptavidin, and Biotin conjugated quantum dots are available in wide range of wavelengths.
[67]
Selah Technologies LLC Selah Dots™
Selah Dots™ are patent-pending photoluminescent carbonbased nanoparticles. Selah Tubes™ are enriched for various applications.
[68]
Helicos Biosciences Corp
QDs Biomarker tSMS
Helicos developed quantum dots, used as biomarker for the analysis of large quantities of genetic material by directly sequencing single molecules of deoxyribonucleic acid (DNA) or single DNA copies of ribonucleic acid (RNA) (cDNA) and its approach of direct sequencing of RNA. Helicos uses True Single Molecule Sequencing (tSMS) technology for the analysis of macromolecules.
[69] ing QDs surface with a protecting and stabilizing shell, in order to use them safely for subsequent bioconjugation with macromolecules or other chemical moieties.
